These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

222 related items for PubMed ID: 20875336

  • 21. The first decade of biologic TNF antagonists in clinical practice: lessons learned, unresolved issues and future directions.
    Sfikakis PP.
    Curr Dir Autoimmun; 2010; 11():180-210. PubMed ID: 20173395
    [Abstract] [Full Text] [Related]

  • 22. Alopecia areata during treatment of psoriasis with adalimumab and leflunomide: a case and review of the literature.
    Navarro R, Daudén E, Gallo E, Santiago Sánchez-Mateos D, García-Diez A.
    Skin Pharmacol Physiol; 2012; 25(2):107-10. PubMed ID: 22301842
    [Abstract] [Full Text] [Related]

  • 23. Adalimumab-induced psoriatic alopecia/alopecia areata-like reaction in a patient with Crohn's disease.
    Toda-Brito H, Lopes L, Soares-Almeida L, Filipe P.
    Dermatol Online J; 2015 Nov 18; 21(11):. PubMed ID: 26632930
    [Abstract] [Full Text] [Related]

  • 24. Differential effectiveness of etanercept and infliximab in the treatment of ocular inflammation.
    Galor A, Perez VL, Hammel JP, Lowder CY.
    Ophthalmology; 2006 Dec 18; 113(12):2317-23. PubMed ID: 16996615
    [Abstract] [Full Text] [Related]

  • 25. Successful treatment of severe Behçet's disease with infliximab in an Italian Olympic athlete.
    Olivieri I, Latanza L, Siringo S, Peruz G, Di Iorio V.
    J Rheumatol; 2008 May 18; 35(5):930-2. PubMed ID: 18464316
    [Abstract] [Full Text] [Related]

  • 26. Effects of anti-TNF-alpha antibody infliximab in refractory entero-Behcet's disease.
    Iwata S, Saito K, Yamaoka K, Tsujimura S, Nawata M, Suzuki K, Tanaka Y.
    Rheumatology (Oxford); 2009 Aug 18; 48(8):1012-3. PubMed ID: 19465589
    [No Abstract] [Full Text] [Related]

  • 27. De novo tuberculosis during infliximab therapy in a patient with Behçet disease.
    Skvara H, Duschek N, Karlhofer F.
    J Dtsch Dermatol Ges; 2009 Jul 18; 7(7):616-9. PubMed ID: 19192011
    [Abstract] [Full Text] [Related]

  • 28. Potential target of infliximab in autoimmune and inflammatory diseases.
    Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P.
    Autoimmun Rev; 2007 Sep 18; 6(8):529-36. PubMed ID: 17854744
    [Abstract] [Full Text] [Related]

  • 29. Sustained remission after infliximab in a child with vasculitis refractory to conventional immunosuppressives including interferon-alpha.
    Evereklioglu C, Borlu M.
    Br J Ophthalmol; 2008 Aug 18; 92(8):1034, 1148-9. PubMed ID: 18653594
    [No Abstract] [Full Text] [Related]

  • 30. Recurrence of alopecia areata in a patient receiving etanercept injections.
    Posten W, Swan J.
    Arch Dermatol; 2005 Jun 18; 141(6):759-60. PubMed ID: 15967923
    [Abstract] [Full Text] [Related]

  • 31. What is the association between the tumor necrosis factor-alpha inhibitor infliximab and complex regional pain syndrome type I?
    Paraskevas KI.
    Paediatr Anaesth; 2008 Jul 18; 18(7):689-90. PubMed ID: 18331547
    [No Abstract] [Full Text] [Related]

  • 32. Alopecia areata during treatment with biologic agents.
    Tosti A, Pazzaglia M, Starace M, Bellavista S, Vincenzi C, Tonelli G.
    Arch Dermatol; 2006 Dec 18; 142(12):1653-4. PubMed ID: 17179002
    [No Abstract] [Full Text] [Related]

  • 33. Improvement of idiopathic pyoderma gangrenosum during treatment with anti-tumor necrosis factor alfa monoclonal antibody.
    Dini V, Romanelli M, Bertone M, Talarico S, Bombardieri S, Barachini P.
    Int J Low Extrem Wounds; 2007 Jun 18; 6(2):108-13. PubMed ID: 17558009
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 37. Comparison of infliximab versus ciclosporin during the initial 6-month treatment period in Behçet disease.
    Yamada Y, Sugita S, Tanaka H, Kamoi K, Kawaguchi T, Mochizuki M.
    Br J Ophthalmol; 2010 Mar 18; 94(3):284-8. PubMed ID: 19692382
    [Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.